Bausch Health Companies (BHC) Total Liabilities (2009 - 2026)
Bausch Health Companies (BHC) reported Total Liabilities of $25.6 billion for Q1 2026, down 4.05% on a YoY basis from $26.7 billion in Q1 2025, and down 1.57% sequentially from $26.0 billion in Q4 2025.
Bausch Health Companies (BHC) Total Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Total Liabilities data on file, last reported at $25.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 4.05% year-over-year to $25.6 billion; the trailing twelve-month figure through Mar 2026 stood at $25.6 billion (down 4.05% YoY), and the FY2025 full-year result was $26.0 billion, down 3.19% from the prior year.
- Total Liabilities eased to $25.6 billion in Q1 2026, from $26.0 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $29.2 billion in Q1 2022 to a low of $25.2 billion in Q2 2023.
- A 5-year average of $26.6 billion and a median of $26.7 billion in 2024 frame the typical range for Total Liabilities.
- Peak annual rise in Total Liabilities reached 7.89% in 2023, while the deepest fall reached 13.45% in 2023.
- Tracing BHC's Total Liabilities over 5 years: stood at $25.4 billion in 2022, then increased by 7.89% to $27.4 billion in 2023, then decreased by 2.14% to $26.8 billion in 2024, then retreated by 3.19% to $26.0 billion in 2025, then slipped by 1.57% to $25.6 billion in 2026.
- Business Quant data shows BHC's Total Liabilities at $25.6 billion in Q1 2026, $26.0 billion in Q4 2025, and $26.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 25.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.58 Bn |
| Dec 31, 2025 | 25.99 Bn |
| Sep 30, 2025 | 26.47 Bn |
| Jun 30, 2025 | 27.12 Bn |
| Mar 31, 2025 | 26.66 Bn |
| Dec 31, 2024 | 26.85 Bn |
| Sep 30, 2024 | 26.78 Bn |
| Jun 30, 2024 | 26.72 Bn |
| Mar 31, 2024 | 27.09 Bn |
| Dec 31, 2023 | 27.43 Bn |
| Sep 30, 2023 | 27.30 Bn |
| Jun 30, 2023 | 25.23 Bn |
| Mar 31, 2023 | 25.30 Bn |
| Dec 31, 2022 | 25.43 Bn |
| Sep 30, 2022 | 25.87 Bn |
| Jun 30, 2022 | 27.92 Bn |
| Mar 31, 2022 | 29.23 Bn |
| Dec 31, 2021 | 29.24 Bn |
| Sep 30, 2021 | 29.39 Bn |
| Jun 30, 2021 | 30.65 Bn |